|
|
FOR IMMEDIATE RELEASE
ACNielsen HCI Answers Frequently Asked Promotional Questions for Pharmaceutical Executives
– Answers Help to Improve Promotion and Sales Efficiency –
PRINCETON, NJ - May 03, 2003 - ACNielsen HCI, a national pharmaceutical promotion research
organization and recognized leader in physician and consumer promotion planning and measurement,
announced today the introduction of its new website feature, which provides answers to the most frequently
asked promotion questions by pharmaceutical company executives. The new website feature, located
at www.acnielsenhci.com/faqs_mstr.html, will address a different question two times each month through
the end of 2003 to assist pharmaceutical companies in improving the effectiveness and efficiency of
their promotional programs.
The website feature also contains a section where visitors can submit their own questions relating to
pharmaceutical promotional planning and executives from ACNielsen HCI will post responses. Those responses
and answers to other frequently asked questions will be archived on an ongoing basis for future reference.
Questions will be related to the following topics including:
- Core messages
- Sales effort
- Professional advertising
- ROI/maximizing promotional efficiency
- Promotional Do's and Don'ts
"ACNielsen HCI's experience in working with 33 of the top 50 pharmaceutical companies to provide tracking
services that monitor the effectiveness of promotional campaigns has enabled us to compile a series of
well-documented promotional guidelines and expectations that we believe will help pharmaceutical companies
to develop and implement better promotional programs," said C. Marshall Paul, president, ACNielsen HCI.
"Our seasoned expertise in the industry has helped companies turn data into sales and has made us a trusted
asset to pharmaceutical companies nationwide."
ACNielsen HCI addresses marketing challenges that sales, product and brand managers and research
professionals encounter every day - from pre-launch research including budgeting, promotional launch planning,
and effectiveness of positioning and messaging to post-launch research that evaluates the impact of specific
campaigns along with the effectiveness of the marketing and sales force strategies that attend them.
Working in partnership with the industry's top pharmaceutical professionals for two decades, ACNielsen HCI
is the only pharmaceutical promotion research organization serving the pharmaceutical industry that provides
integrated quantitative (Rx) and qualitative (attitudinal) research analysis with recommendations on how
to proceed. Once information is collected, the research is compared to norms that are drawn from a
database of more than 6,800 medical campaigns which ACNielsen HCI has monitored and analyzed over the last
18 years and 60+ consumer campaigns monitored in the last several years.
The company has deep norms in most therapeutic areas, as well as by product type. To monitor the success
of promotional strategies over time, ACNielsen HCI leverages tracking research, which examines subtle
changes and shifts in a specific population's attitudes, and knowledge and opinions of a product, service
or company or therapy area over time.
For more information about ACNielsen HCI and its services, visit the website at
www.acnielsenhci.com, call toll-free
800-660-8443 or e-mail at cmpaul@acnielsenhci.com.
About ACNielsen HCI
Based in Princeton, NJ, ACNielsen HCI is a national pharmaceutical promotion research organization and a
recognized leader in physician and consumer promotion planning, measurement and analysis. Since 1982,
ACNielsen HCI's strategic promotion planning and evaluation expertise has powered sales, profitability
and competitive advantage for pharmaceutical companies through the application of its unique blend of
integrated quantitative and qualitative research. Leveraging the insight, knowledge and deep normative data
gathered through analysis of more than 6,400 promotional campaigns, ACNielsen HCI provides research
solutions addressing critical marketing and sales issues. The company has strong and deep norms in most
therapeutic areas.
|
|
|
|
|
|